An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
Clinical trial NCT05243680 · COMPLETED
Trial details
- NCT number
- NCT05243680
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-01
- Primary completion
- 2025-05-19
- Enrollment
- 641
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.